These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21920248)

  • 1. Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
    Levine D; Ananthakrishnan S; Garg A
    J Am Acad Dermatol; 2011 Oct; 65(4):877-878. PubMed ID: 21920248
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors.
    Fessler D; Beach J; Keel J; Stead W
    Pain Physician; 2012; 15(6):489-93. PubMed ID: 23159966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 23778239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting HIV treatment options: good news, new challenges.
    Cahn P; Sued O
    J Infect Dis; 2013 Jul; 208(1):4-6. PubMed ID: 23532095
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults.
    von Hentig N; Dauer B; Haberl A; Klauke S; Lutz T; Staszewski S; Harder S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):935-40. PubMed ID: 17665183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir.
    Yombi JC; Maiter D; Belkhir L; Nzeusseu A; Vandercam B
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S79-82. PubMed ID: 18827959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluticasone-ritonavir: a drug-drug interaction causing iatrogenic Cushing's syndrome and adrenal insufficiency].
    Rousseau C; Dolz M
    Med Mal Infect; 2014 Oct; 44(10):483-4. PubMed ID: 25282607
    [No Abstract]   [Full Text] [Related]  

  • 8. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 25513635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urolithiasis under atazanavir boosted and tenofovir therapy: a case report.
    D'Ettorre G; Zaffiri L; Ceccarelli G; Massetti AP; Mastroianni CM; Vullo V
    J Chemother; 2008 Feb; 20(1):143-4. PubMed ID: 18343760
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
    Perez-Molina JA; Rubio R; Rivero A; Pasquau J; Suárez-Lozano I; Riera M; Estébanez M; Santos J; Sanz-Moreno J; Troya J; Mariño A; Antela A; Navarro J; Esteban H; Moreno S;
    Lancet Infect Dis; 2015 Jul; 15(7):775-84. PubMed ID: 26062881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atazanavir-induced nephrolithiasis].
    Valencia ME; Moreno V
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):134-5. PubMed ID: 19246127
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report.
    Celesia BM; Onorante A; Nunnari G; Mughini MT; Mavilla S; Massimino SD; Russo R
    AIDS; 2007 Jul; 21(11):1495-6. PubMed ID: 17589203
    [No Abstract]   [Full Text] [Related]  

  • 13. Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome.
    Albert NE; Kazi S; Santoro J; Dougherty R
    Am J Med Sci; 2012 Jul; 344(1):72-4. PubMed ID: 22543594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.
    Dailly E; Tribut O; Tattevin P; Arvieux C; Perré P; Raffi F; Jolliet P
    Eur J Clin Pharmacol; 2006 Jul; 62(7):523-6. PubMed ID: 16763827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
    Johnson SR; Marion AA; Vrchoticky T; Emmanuel PJ; Lujan-Zilbermann J
    J Pediatr; 2006 Mar; 148(3):386-8. PubMed ID: 16615973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cushing's syndrome induced by combined treatment with inhaled fluticasone and oral ritonavir].
    Dupont C; Giraud V; Leporrier J; Greffe S; Rouveix E; Chinet T
    Rev Mal Respir; 2009 Sep; 26(7):779-82. PubMed ID: 19953021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir.
    Hall JJ; Hughes CA; Foisy MM; Houston S; Shafran S
    Int J STD AIDS; 2013 Sep; 24(9):748-52. PubMed ID: 23970582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iatrogenic Cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIV-infected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists.
    Grierson MJ; Harrast MA
    PM R; 2012 Mar; 4(3):234-7. PubMed ID: 22443962
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
    St Germain RM; Yigit S; Wells L; Girotto JE; Salazar JC
    AIDS Patient Care STDS; 2007 Jun; 21(6):373-7. PubMed ID: 17594245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
    Elion R; Berger D; Richmond G; Sension M; Dejesus E; Cimoch P; St Clair M; Yau L; Ha B;
    HIV Clin Trials; 2010; 11(3):170-3. PubMed ID: 20736153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.